Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Challenges in tuberculosis screening before TNF-α inhibitors: A case report highlighting gaps in current practice.

Journal of clinical tuberculosis and other mycobacterial diseases·2026
Same author

Implementing Digital Respiratory Technologies for People With Respiratory Conditions: Scoping Review.

Journal of medical Internet research·2026
Same author

Breathing and speech patterns for predictive modelling of exacerbations of asthma and COPD.

Respiratory medicine·2026
Same author

Bidirectional Clinical Interactions among Exacerbations and Comorbidities in COPD: A Narrative Review.

Seminars in respiratory and critical care medicine·2026
Same author

Assessing Lifestyle Goal Setting in Patients with COPD.

International journal of chronic obstructive pulmonary disease·2026
Same author

Associations of chrono-nutrition with sleep and quality of life: The Maastricht Study.

Clinical nutrition (Edinburgh, Scotland)·2026

Related Experiment Video

Updated: May 30, 2026

A High-throughput Compatible Assay to Evaluate Drug Efficacy against Macrophage Passaged Mycobacterium tuberculosis
10:29

A High-throughput Compatible Assay to Evaluate Drug Efficacy against Macrophage Passaged Mycobacterium tuberculosis

Published on: March 24, 2017

Drug susceptibility testing for optimizing tuberculosis treatment.

Sami O Simons1, Dick van Soolingen

  • 1Radboud University Medical Centre, the Netherlands National Institute for Public Health and the Environment, Bilthoven, The Netherlands. s.simons@long.umcn.nl

Current Pharmaceutical Design
|August 13, 2011
PubMed
Summary

Drug susceptibility testing (DST) for tuberculosis (TB) needs rapid advancements. New molecular methods significantly cut diagnosis time, crucial for controlling multidrug-resistant TB.

Related Experiment Videos

Last Updated: May 30, 2026

A High-throughput Compatible Assay to Evaluate Drug Efficacy against Macrophage Passaged Mycobacterium tuberculosis
10:29

A High-throughput Compatible Assay to Evaluate Drug Efficacy against Macrophage Passaged Mycobacterium tuberculosis

Published on: March 24, 2017

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Clinical Diagnostics

Background:

  • Current tuberculosis drug susceptibility testing (DST) methods, established in 1963, face challenges due to long turnaround times and limited laboratory capacity.
  • The rise of multidrug-resistant tuberculosis (MDR-TB) necessitates rapid and accurate DST to guide effective treatment strategies.
  • Despite advancements, a significant gap persists in the widespread availability and implementation of rapid DST for Mycobacterium tuberculosis.

Purpose of the Study:

  • To provide a comprehensive overview of current and emerging drug susceptibility testing (DST) methodologies for tuberculosis (TB).
  • To discuss the characteristics, biosafety, reproducibility, and quality control of various DST techniques.
  • To explore the role of pharmacodynamic studies and identify future research directions in TB resistance.

Main Methods:

  • Review of existing literature on tuberculosis drug susceptibility testing (DST) methods.
  • Analysis of semi-automated liquid culture systems and molecular diagnostic techniques (e.g., reverse line probe assays, real-time PCR).
  • Inclusion of findings from recent pharmacodynamic studies relevant to TB treatment resistance.

Main Results:

  • Semi-automated liquid culture systems and molecular methods like real-time PCR have significantly reduced DST turnaround times from days to hours.
  • Pharmacodynamic studies offer valuable insights into the mechanisms of drug resistance development during TB treatment.
  • Established DST techniques require rigorous quality control and assessment of biosafety and reproducibility.

Conclusions:

  • Drug susceptibility testing (DST) is an essential tool for effective tuberculosis (TB) control and the prevention of drug resistance.
  • Implementing DST for all TB patients is crucial for guiding appropriate treatment decisions.
  • Future research should focus on developing faster phenotypic and molecular DST methods and exploring individualized treatment dosages to combat resistance.